FLNA — FILANA THERAPEUTICS, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1069530 ·
Last close
$0.48
Market Cap
$24.19M
52W High
$3.45
52W Low
$0.39
ADV30
427,433
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -11,274,000 -10,726,000 100,058,000 46,990,000 42,082,000
Jun 2026 0 — -9,393,000 -8,603,000 103,903,000 82,681,000 40,294,000
Mar 2026 0 — -11,168,000 -10,331,000 108,367,000 86,573,000 40,226,000
Dec 2025 0 — -14,288,000 -12,539,000 118,355,000 95,502,000 43,952,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-28,702,000
Investing CF
$-581,000
Financing CF
$-396,000
CapEx
$-501,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.87
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-515,018,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-46,709,000
Pretax Income TTM
$-42,280,000
Interest Exp TTM
—
Analysts
2

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -96,126,000 -90,973,000 118,355,000 43,952,000 74,403,000 -32,252,000
Dec 2024 0 -142,279,000 -24,342,000 157,533,000 11,829,000 145,704,000 -116,929,000
Dec 2023 0 -107,333,000 -97,217,000 151,663,000 14,195,000 137,468,000 -82,025,000
Dec 2022 0 -81,482,000 -76,246,000 234,834,000 7,295,000 227,539,000 -77,514,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-42,280,000
OpCashFlow TTM
—
Assets (Latest)
$103,903,000
Forward EPS
—

Max Pain — expiry 2028-01-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $1.00 · spot: $0.55 · call volume: 2 · put volume: 808
Expected Move to 2028-01-21: ±$0.45 (81.82%) — implied range $0.10 – $1.00 · ATM straddle on $0.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CLCS Cell Source, Inc. $25.14M $0.37 —
AARD Aardvark Therapeutics, Inc. $25.17M $1.15 —
ETST Earth Science Tech, Inc. $23.17M $0.08 —
BIOE Bio Essence Corp $25.29M $0.47 —
ABVC ABVC BIOPHARMA, INC. $25.36M $0.94 —

News headlines (Yahoo Finance, 1h cache)

Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board
2026-11-11 13:00 · Yahoo
Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update
2026-11-05 13:00 · Yahoo
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
2026-10-28 12:00 · Yahoo
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
2026-10-09 12:00 · Yahoo
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
2026-09-22 12:00 · Yahoo
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
2026-07-29 12:00 · Yahoo
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
2026-05-07 12:00 · Yahoo
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
2026-05-05 12:00 · Yahoo
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
2026-04-15 12:00 · Yahoo
Data I/O And 2 Other Promising Penny Stocks To Watch
2026-05-29 18:05 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-11-18 16:13:24 2026-11-16 Barry Richard Pres, CEO P - Purchase 0.47 440206 206897
2026-11-18 16:05:35 2026-11-16 Cook Robert Christopher COO,Legal Officer P - Purchase 0.46 121575 55925